Cargando…
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker
SIMPLE SUMMARY: Immune checkpoint inhibitors (ICI) have revolutionized cancer care. However, assessing the efficacy of these new molecules with targeted therapeutic responses may induce too much delay when using classical biomarkers derived from morphological imaging (CT). The objective of our study...
Autores principales: | Naccache, Raphael, Belkouchi, Younes, Lawrance, Littisha, Benatsou, Baya, Hadchiti, Joya, Cournede, Paul-Henry, Ammari, Samy, Talbot, Hugues, Lassau, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909556/ https://www.ncbi.nlm.nih.gov/pubmed/35267645 http://dx.doi.org/10.3390/cancers14051337 |
Ejemplares similares
-
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs
por: Decazes, Pierre, et al.
Publicado: (2023) -
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
por: Belkouchi, Younes, et al.
Publicado: (2022) -
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer
por: Decazes, Pierre, et al.
Publicado: (2023) -
Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion
por: Li, Yingping, et al.
Publicado: (2022) -
BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model
por: Courcier, Jean, et al.
Publicado: (2023)